Research programme: molecular glue degrader analogues - Pin Therapeutics
Alternative Names: MGD analogsLatest Information Update: 06 Jan 2023
At a glance
- Originator Pin Therapeutics
- Class Antineoplastics; Peptides
- Mechanism of Action Casein kinase Ialpha inhibitors; Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Acute myeloid leukaemia